These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 30327875

  • 81. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
    Hiyama T, Haruma K, Kitadai Y, Ito M, Masuda H, Miyamoto M, Tanaka S, Yoshihara M, Sumii K, Shimamoto F, Chayama K.
    Int J Oncol; 2001 Jun; 18(6):1207-12. PubMed ID: 11351252
    [Abstract] [Full Text] [Related]

  • 82. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome.
    Choi YJ, Kim N, Paik JH, Kim JM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC.
    Helicobacter; 2013 Jun; 18(3):197-205. PubMed ID: 23305046
    [Abstract] [Full Text] [Related]

  • 83. Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy.
    Cammarota G, Tursi A, Montalto M, Papa A, Branca G, Vecchio FM, Renzi C, Verzí A, Armuzzi A, Pretolani S.
    J Clin Gastroenterol; 1995 Sep; 21(2):118-22. PubMed ID: 8583076
    [Abstract] [Full Text] [Related]

  • 84. Regression of EI2-stage low-grade gastric MALT-lymphoma after H. pylori eradication.
    Cammarota G, Fedeli P, Bianchi A, Cianci R, Martino A, Fedeli G, Gasbarrini G.
    Hepatogastroenterology; 2005 Sep; 52(63):975-7. PubMed ID: 15966244
    [Abstract] [Full Text] [Related]

  • 85. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial.
    Gunther JR, Xu J, Bhutani MS, Strati P, Fang PQ, Wu SY, Dabaja BS, Dong W, Bhosale PR, Flowers CR, Nair R, Malpica Castillo L, Fayad L, Iyer SP, Parmer S, Wang M, Lee HJ, Samaniego F, Westin J, Ahmed S, Nze CC, Jain P, Neelapu SS, Rodriguez MA, Chihara D, Nastoupil LJ, Pinnix CC.
    Lancet Haematol; 2024 Jul; 11(7):e521-e529. PubMed ID: 38843856
    [Abstract] [Full Text] [Related]

  • 86. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study.
    Montalban C, Santón A, Redondo C, García-Cosio M, Boixeda D, Vazquez-Sequeiros E, Norman F, de Argila CM, Alvarez I, Abraira V, Bellas C.
    Ann Oncol; 2005 Sep; 16(9):1539-44. PubMed ID: 15946976
    [Abstract] [Full Text] [Related]

  • 87. A prospective analysis of efficacy and long-term outcome of radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma.
    Okada H, Takemoto M, Kawahara Y, Nasu J, Takenaka R, Kawano S, Inoue M, Ichimura K, Tanaka T, Shinagawa K, Yoshino T, Yamamoto K.
    Digestion; 2012 Sep; 86(3):179-86. PubMed ID: 22907329
    [Abstract] [Full Text] [Related]

  • 88. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.
    Wündisch T, Thiede C, Morgner A, Dempfle A, Günther A, Liu H, Ye H, Du MQ, Kim TD, Bayerdörffer E, Stolte M, Neubauer A.
    J Clin Oncol; 2005 Nov 01; 23(31):8018-24. PubMed ID: 16204012
    [Abstract] [Full Text] [Related]

  • 89. [Sustained Complete Remission after Eradication Therapy in A Helicobacter pylori-Negative Cecum Mucosa-Associated Lymphoid Tissue Lymphoma].
    Mitsuyama Y, Sata H, Yasumi M, Imakita M, Karasuno T.
    Gan To Kagaku Ryoho; 2020 Oct 01; 47(10):1513-1515. PubMed ID: 33130753
    [Abstract] [Full Text] [Related]

  • 90.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 91. Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
    Asano N, Iijima K, Terai S, Jin X, Ara N, Chiba T, Fushiya J, Koike T, Imatani A, Shimosegawa T.
    Tohoku J Exp Med; 2012 Nov 01; 228(3):223-7. PubMed ID: 23076291
    [Abstract] [Full Text] [Related]

  • 92.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 93.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 94.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 95. Helicobacter and gastric MALT lymphoma.
    Stolte M, Bayerdörffer E, Morgner A, Alpen B, Wündisch T, Thiede C, Neubauer A.
    Gut; 2002 May 01; 50 Suppl 3(Suppl 3):III19-24. PubMed ID: 11953328
    [Abstract] [Full Text] [Related]

  • 96. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori.
    Falcó Jover G, Martínez Egea A, Sánchez Cuenca J, Onrubia Pintado J, García Lafuente N, Ruiz Gómez F, Coronas Planas M.
    Rev Esp Enferm Dig; 1999 Aug 01; 91(8):541-8. PubMed ID: 10491486
    [Abstract] [Full Text] [Related]

  • 97. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
    Asano N, Iijima K, Koike T, Imatani A, Shimosegawa T.
    World J Gastroenterol; 2015 Jul 14; 21(26):8014-20. PubMed ID: 26185372
    [Abstract] [Full Text] [Related]

  • 98. Efficacy of eradication therapy in Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: A meta-analysis.
    Jung K, Kim DH, Seo HI, Gong EJ, Bang CS.
    Helicobacter; 2021 Apr 14; 26(2):e12774. PubMed ID: 33400830
    [Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.